TFPI2 and neoplasm: While it is clear that TFPI-2 methylation profiling allows clinical samples to be discriminated, the difference in TFPI-2 mRNA expression between tumor and normal tissues was not as convincing as was expected (data not shown), mostly due to the heterogeneity of OSCC tissue specimens, in which both TFPI-2-expressing and nonexpressing cells were present [41].